Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding
Then, on April 30, 2026, FDA proposed excluding tirzepatide, semaglutide, and liraglutide from the 503B bulks list because FDA did not identify a clinical need for large-scale outsourcing facilities to compound them from bulk substances
You can still get a productive workout
J Vet Intern Med 32(6):18561863 Mostaghni K, Badiei K, Khodakaram-Tafti A, Bashari Maafi A (2008) Pathological and biochemical studies of experimental hypothyroidism in sheep
From both the mechanistic and clinical standpoints, it is reasonable to expect that GLP-1s and SGLT2s would produce additive CV and renal protective effects
Prioritizing sleep is also important